Kallen graduated from the University of Michigan in the spring of 2018 with a degree in Biomedical Engineering and matriculated in the University of Michigan MSTP in the fall of 2018. His undergraduate research focused on developing transcription factor activity assays and the systems biology of drug resistance in breast cancer. On the clinical side, he is interested in pathology.
Overcoming drug resistance in high-grade gliomas
Neurosphere and adherent cell culture, proliferation assays, immunoblotting